Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open‐label, multicentre, 12‐week phase III study
Fumihiko Koiwa; Keitaro Yokoyama; Masafumi Fukagawa; Akira Terao; Tadao Akizawa
Author Information: Division of Nephrology, Department of Medicine
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.